Regional and neuronal reductions of polyadenylated messenger RNA in Alzheimer's disease.
Harrison PJ, Barton AJ, Najlerahim A, McDonald B, Pearson RC
Purpose
The purpose of this paper was to examine the effect of postmortem interval (PMI) (6-86 h), rapidity of death, patient age, and Alzheimer's disease on polyadenylated (poly(A)) mRNA in situ hybridization signal in different brain regions.
Conclusion
PMI did not significantly alter quantifiable poly(A) mRNA levels in control (7-70 h) or Alzheimer's disease (6-86) brain specimens, although a nonsignificant reduction in poly(A) mRNA was observed with increasing PMI. Rapidity of death did not affect poly(A) levels in control brains, but prolonged coma and slow deterioration significantly reduced poly(A) in the visual cortex of Alzheimer's disease brain specimens. Advancing age led to a significant reduction in poly(A) in hippocampal regions CA1 and CA4 (51-96 y)of control specimens; similar, but nonsignificant, trends were also observed in other brain regions and in Alzheimer's disease specimens. Poly(A) mRNA levels were significantly lower in Alzheimer's disease specimens compared to normal controls (69-73% of normal controls) in the hippocampal region CA3, the granular layer of the cerebellum, and when examined at the cellular level in the temporal cortex. Similar, but nonsignificant, trends were observed among other brain regions and non-Alzheimer's dementia specimens. The authors conclude that poly(A) mRNA levels were not impacted by PMI, but may be influenced by rapidity of death, patient age and Alzheimer's disease.
Studies (2)
Purpose
The purpose of this study was to examine the effect of postmortem interval (PMI) (6-86 h), rapidity of death, and patient age on poly(A) mRNA levels, as quantified by in situ hybridization, in different brain regions. Of note, brain specimens were stored at -70 degrees C for 2-24 months prior to analysis.
Summary of Findings
PMI did not significantly alter quantifiable poly(A) mRNA levels in control (7-70 h) or Alzheimer's disease (6-86) brain specimens, although a nonsignificant reduction in poly(A) mRNA was observed with increasing PMI regardless of disease state (r = -0.04 to -0.48). No effect of rapidity of death was observed in control brain specimens, but prolonged coma or slow patient deterioration resulted in a decline in poly(A) signal in the visual cortex of Alzheimer's disease brain specimens. In control brains, advancing age (51-96 y) led to reduced poly(A) mRNA levels in hippocampal regions CA1 and CA4 (p<0.05); similar, but nonsignificant trends were also observed in other brain regions and in Alzheimer's disease specimens. The authors conclude that rapidity of death and patient age can alter poly(A) mRNA levels, but that any effect of PMI in the first 86 h is insignificant.
Biospecimens
TissueBrainPreservation Types
FrozenDiagnoses
NormalAlzheimer's DiseaseAutopsyHuntington's DiseaseOther diagnosesPlatforms
RNAIn situ hybridizationPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Alzheimer's diseaseControlNon-Alzheimer's dementiaPreaquisition Patient age 51-96 yPreaquisition Postmortem interval 6-86 hPreaquisition Rapidity of death Coma of less than 12 h or evidence of pyrexia or dehydrationComa of more than 12 hSudden deathBiospecimen Acquisition Biospecimen location Dentate gyrusGranular layer of cerebellumHippocampus region CA1Hippocampus region CA2Hippocampus region CA3Hippocampus region CA4Temporal cortexVisual cortex
Purpose
The purpose of this study was to examine the effect of Alzheimer's disease on poly(A) mRNA levels, as quantified by in situ hybridization, in different brain regions.
Summary of Findings
Alzheimer's disease brains displayed an overall reduction in poly(A) mRNA content in hippocampal region CA3 (69% of control; p<0.05) and the granular layer of the cerebellum (73% of control; p<0.01), and the temporal cortex (73% of controls; p<0.02) compared to control specimens. In comparison to control specimens, poly (A) levels were nonsignificantly reduced in Alzheimer's disease hippocampal regions CA1 and C4 and the dentate gyrus. Levels of poly(A) RNA were comparable in the visual cortex among of Alzheimer's disease and control specimens. Brain specimens from patients diagnosed with non-Alzheimer's dementia displayed similar nonsignificant reductions in poly(A) mRNA, although only 4 cases were assessed. The ratio of poly(A) ISH signal in hippocampal regions CA1 to CA3 was also reduced in this diagnostic group compared to normal controls (83% of control; p<0.05). The authors conclude that levels of poly(A) mRNA differ in specific brain regions of Alzheimer's disease specimens compared to neurological normal controls.
Biospecimens
TissueBrainPreservation Types
FrozenDiagnoses
NormalAlzheimer's DiseaseAutopsyHuntington's DiseaseOther diagnosesPlatforms
RNAIn situ hybridizationPre-analytical Factors
Classification Pre-Analytical Factor Value(s) Preaquisition Diagnosis/ patient condition Alzheimer's diseaseControlNon-Alzheimer's dementiaBiospecimen Acquisition Biospecimen location Dentate gyrusGranular layer of cerebellumHippocampus region CA1Hippocampus region CA2Hippocampus region CA3Hippocampus region CA4Temporal cortexVisual cortex